The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
First Evidence For Astrophysical Neutrinos
Scientists have discovered the first solid evidence for astrophysical neutrinos, which will lead to new ways of exploring the universe.
Researchers Construct Largest Quantum Circuit Board Ever
Researchers in Japan and Australia have made a breakthrough in scalability for 'circuit boards' of a quantum computer made out of laser light.
Researchers Discover New Osteoporosis Treatment
Researchers have discovered a promising treatment for osteoporosis called picolinic acid, which rescued bone from menopause-associated osteoporosis in animal studies.
Takeda’s Oral Proteasome Inhibitor MLN9708 Enters Ph III Study In Japan
Takeda has initiated enrollment of patients in Japan in an ongoing global Phase III clinical study of its novel oral proteasome inhibitor MLN9708.
Mallinckrodt, China Resources Pharma To Promote Optiray X-Ray
Mallinckrodt Pharmaceuticals has partnered with China Resources Pharma to promote its Optiray™ (ioversol injection) x-ray contrast media in China.
Medifocus, Ideal Concept JV To Market Prolieve Treatment
Medifocus has entered into a joint venture agreement with Ideal Concept Group to sell and market its Prolieve treatment in China and other Asian countries.
How An Early Embryo Changes Shape
Scientists have revealed new insights into how cells organize and form an early mammalian embryo.
Merck Invests €80 Million On Pharmaceutical Facility In China
Merck has invested €80 million into a new pharmaceutical manufacturing facility to be located in the Greater Shanghai region, China.
Eli Lilly Funds US$350 Million To Expand Insulin Production In China
Eli Lilly and Company will invest US$350 million to expand its insulin cartridge manufacturing capacity in China.